{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:12:59Z","timestamp":1787317979903,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016944","name":"Regenerative Medicine Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021465","name":"Department of Pathology and Laboratory Medicine, College of Medicine, Medical University of South Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021802","name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jcyt.2024.08.009","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T12:47:24Z","timestamp":1725367644000},"page":"121-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bioreactor on a chip: a microfluidic device for closed production of human dendritic cells"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4020-5188","authenticated-orcid":false,"given":"Kevin","family":"Loutherback","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6629-2338","authenticated-orcid":false,"given":"Peggy","family":"Bulur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3410-9621","authenticated-orcid":false,"given":"Allan B.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jcyt.2024.08.009_bib0001","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/d41573-022-00095-1","article-title":"Landscape of cancer cell therapies: trends and real-world data","volume":"21","author":"Saez-Ibanez","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.jcyt.2024.08.009_bib0002","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1643","article-title":"Dendritic cells: versatile controllers of the immune system","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jcyt.2024.08.009_bib0003","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2096363","article-title":"Trial watch: Dendritic cell (DC)-based immunotherapy for cancer","volume":"11","author":"Laureano","year":"2022","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.jcyt.2024.08.009_bib0004","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jcyt.2024.08.009_bib0005","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2217\/fon-2017-0531","article-title":"Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions","volume":"14","author":"Handy","year":"2018","journal-title":"Future Oncol"},{"issue":"26","key":"10.1016\/j.jcyt.2024.08.009_bib0006","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.23.02585","article-title":"Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer","volume":"42","author":"van \u2019t Land","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jcyt.2024.08.009_bib0007","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1038\/s41467-020-18962-z","article-title":"Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients","volume":"11","author":"Block","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jcyt.2024.08.009_bib0008","first-page":"vdac089","article-title":"Phase I trial of adjuvant mature autologous dendritic cell\/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma","volume":"4","author":"Parney","year":"2022","journal-title":"Neurooncol Adv"},{"issue":"1","key":"10.1016\/j.jcyt.2024.08.009_bib0009","first-page":"vdaa105","article-title":"Novel strategy for manufacturing autologous dendritic cell\/allogeneic tumor lysate vaccines for glioblastoma","volume":"2","author":"Parney","year":"2020","journal-title":"Neurooncol Adv"},{"issue":"4","key":"10.1016\/j.jcyt.2024.08.009_bib0010","first-page":"428","article-title":"Engineering dendritic cell grafts for clinical trials in cellular immunotherapy of cancer: example of chronic myelogenous leukemia","volume":"42","author":"Dietz","year":"2001","journal-title":"Croat Med J"},{"issue":"13","key":"10.1016\/j.jcyt.2024.08.009_bib0011","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1182\/blood-2008-04-149526","article-title":"Dendritic cell microvilli: a novel membrane structure associated with the multifocal synapse and T-cell clustering","volume":"112","author":"Fisher","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jcyt.2024.08.009_bib0012","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood.V91.2.392","article-title":"High efficiency adenovirus-mediated gene transfer to human dendritic cells","volume":"91","author":"Dietz","year":"1998","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcyt.2024.08.009_bib0013","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14653240410005357-1","article-title":"Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanoma","volume":"6","author":"Dietz","year":"2004","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.08.009_bib0014","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2018.09.012","article-title":"Automated closed-system manufacturing of human monocyte-derived dendritic cells for cancer immunotherapy","volume":"463","author":"Erdmann","year":"2018","journal-title":"Journal of Immunological Methods"},{"issue":"11","key":"10.1016\/j.jcyt.2024.08.009_bib0015","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jcyt.2019.09.001","article-title":"Automated Good Manufacturing Practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines","volume":"21","author":"Uslu","year":"2019","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1016\/j.jcyt.2024.08.009_bib0016","doi-asserted-by":"crossref","DOI":"10.1007\/s10404-022-02568-6","article-title":"Capture and reagent exchange (CARE) wells for cell isolation, labeling, and characterization","volume":"26","author":"Loutherback","year":"2022","journal-title":"Microfluidics and Nanofluidics"},{"issue":"6","key":"10.1016\/j.jcyt.2024.08.009_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152744","article-title":"Fluid shear stress enhances dendritic cell activation","volume":"228","author":"Dombroski","year":"2023","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.jcyt.2024.08.009_bib0018","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1038\/s41598-021-91117-2","article-title":"Biomechanical forces enhance directed migration and activation of bone marrow-derived dendritic cells","volume":"11","author":"Kang","year":"2021","journal-title":"Sci Rep"},{"issue":"7250","key":"10.1016\/j.jcyt.2024.08.009_bib0019","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature08073","article-title":"Biomechanical forces promote embryonic haematopoiesis","volume":"459","author":"Adamo","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jcyt.2024.08.009_bib0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.0.CO;2-7","article-title":"Polymer microfabrication methods for microfluidic analytical applications","volume":"21","author":"Becker","year":"2000","journal-title":"Electrophoresis"},{"issue":"4","key":"10.1016\/j.jcyt.2024.08.009_bib0021","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1469-185X.2007.00027.x","article-title":"Effect size, confidence interval and statistical significance: a practical guide for biologists","volume":"82","author":"Nakagawa","year":"2007","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"12","key":"10.1016\/j.jcyt.2024.08.009_bib0022","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/j.1537-2995.2006.01033.x","article-title":"A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers","volume":"46","author":"Dietz","year":"2006","journal-title":"Transfusion"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924008375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924008375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:48:50Z","timestamp":1751381330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324924008375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1465324924008375"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.08.009","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioreactor on a chip: a microfluidic device for closed production of human dendritic cells","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}